Bryn Mawr Trust »

Xeris Pharmaceuticals shares owned by Bryn Mawr Trust

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Bryn Mawr Trust from 13F filings

Historical chart of Bryn Mawr Trust investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Bryn Mawr Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Bryn Mawr Trust

Quarter filed Position value Share count Share price at filing
2024-09-30 $114 40 2.85

More positions owned by Bryn Mawr Trust

Comcast Corp Cl A (CMCSA)
Intuitive Surgical Com New (ISRG)
Apple (AAPL)
Vanguard ETF/USA Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Vanguard Etf/usa Total Stk Mkt (VTI)
Procter & Gamble Company (PG)
iShares ETFs/USA Rus Tp200 Gr Etf (IWY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
SSgA Funds Management Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Core S&p500 Etf (IVV)
iShares ETFs/USA Msci Usa Qlt Fct (QUAL)
BlackRock Fund Advisors Msci Eafe Etf (EFA)

View all positions for Bryn Mawr Trust

Top funds holding Xeris Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
CenterBook Partners
Geode Capital Management
State Street Corporation
Rosalind Advisors
AIGH Capital Management
Morgan Stanley
Renaissance Technologies
Nuveen Asset Management
Northern Trust
AQR Capital Management
Redmile Group

View all funds holding Xeris Pharmaceuticals